Conditions
Conditions
- Cancer prevention
- Cancer treatment
- Lung cancer
- Breast cancer
- Leukemia
- Autoimmune diseases
- Type 1 diabetes
- Lupus
- Multiple Sclerosis
- Crohn's disease
- Inflammatory conditions
- Inflammatory bowel disease
- Chronic Obstructive Pulmonary Disease
- Emphysema
- Chronic bronchitis
- Infectious diseases
- Hepatitis B and C
- HIV
- Cardiovascular diseases
- Stroke
- Hypertension
- Heart failure
- Ischemic heart disease
- Peripheral artery disease
- Neurological disorders
- Traumatic brain injury
- Parkinson's disease
- Spinal Cord Injury
- Autism
- Skin and soft tissue conditions
- Anti-Aging
- Burns and wounds
- Skin ulcers
- Acne scars
- Hair loss
- Psoriasis
- Eczema
- Vitiligo
- Hyperpigmentation
- Metabolic disorders
- Obesity
- Diabetes Type 2
- Eye disorders
- Macular degeneration
- Retinal diseases
- Organ damage
- Liver cirrhosis
- Chronic Kidney Disease
- Renal failure
- Limb ischemia
- Chronic pain syndromes
- Fibromyalgia
- Chronic headaches
- Inherited disorders
- Muscular dystrophy
- Cystic Fibrosis
- Psychiatric conditions
- Depression
- Anxiety disorders
- Reproductive health
- Male and female infertility
- Erectile dysfunction
- Menopause
Crohn’s disease
Crohn’s Disease can have a profound impact on an individual’s quality of life. Often, traditional treatment options yield limited success, and the side effects of medications can necessitate even more medication to manage them. Unfortunately, these drugs may ultimately fail to provide the desired relief.
The Promise of Stem Cells for Crohn’s Disease
Recent scientific studies have illuminated the remarkable effectiveness of mesenchymal stem cell therapy for inflammatory diseases like Crohn’s. For instance, a 2018 study revealed that mesenchymal stem cells orchestrate both local and systemic innate and adaptive immune responses through the release of various mediators, including immunosuppressive molecules, growth factors, exosomes, chemokines, complement components, and various metabolites.
Another groundbreaking study from 2019 specifically focused on the effectiveness of mesenchymal stem cells in treating perianal Crohn’s Disease. The results were nothing short of remarkable, with significant symptom alleviation and healing observed.
Protocol
Our innovative protocol spans two days and includes the intravenous transplantation of a minimum of 120 million cord tissue-derived MSCs (Mesenchymal Stem Cells). This minimally invasive procedure takes approximately 45 minutes, with minimal downtime. Patients typically return home just two days following their scheduled appointment.
Intravenous transplantation of cord tissue-derived Mesenchymal Stem Cells. This minimally invasive procedure, taking approximately 45 minutes, involves minimal downtime. Patients typically return home just two days following their scheduled appointment.
Studies
Grim, C., Noble, R., Uribe, G., Khanipov, K., Johnson, P., Koltun, W. A., Watts, T., Fofanov, Y., Yochum, G. S., Powell (2021). Impairment of Tissue-Resident Mesenchymal Stem Cells in Chronic Ulcerative Colitis and Crohn’s Disease. Journal of Crohn’s & colitis, 15(8), 1362–1375. https://pubmed.ncbi.nlm.nih.gov/33506258/
Markov, A., Thangavelu, L., Aravindhan, S., Zekiy, A. O., Jarahian, M., Chartrand, M. S., Pathak, Y., Marofi, F., Shamlou, S., & Hassanzadeh, A. (2021). Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders. Stem Cell research & therapy, 12(1), 192. https://stemcellres.biomedcentral.com/articles/10.1186/s13287-021-02265-1
